Executive Moves Ventripoint names Justin Leushner as CEO Justin Leushner Ventripoint Diagnostics (TSXV:VPT; OTC:VPTDF) appointed Justin Leushner as CEO, replacing Dr. George Adams, who was elected chairman of the board. Mr. Leushner, who was named president of... November 4, 2019